Keith R. Campbell, PharmD, MBA, CDE

Article

Pathophysiology of type 2 diabetes mellitus: potential role of incretin-based therapies

Author:: Keith R. Campbell, PharmD, MBA, CDE; Michael E. Cobble, MD, FNLA; Timothy S. Rei

Read More

Article

Pathophysiology of type 2 diabetes mellitus: potential role of incretin-based therapies

Author:: Keith R. Campbell, PharmD, MBA, CDE; Michael E. Cobble, MD, FNLA; Timothy S. Reid, MD; Mansur E. Shomali, MD, CM

Read More

Article

Glucose-lowering effects of incretin-based therapies

Author:: Keith R. Campbell, PharmD, MBA, CDE; Michael E. Cobble, MD, FNLA; Timothy S. Reid, MD; Mansur E. Shomali, MD, CM

Read More

Article

Glucose-lowering effects of incretin-based therapies

Author:: Keith R. Campbell, PharmD, MBA, CDE; Michael E. Cobble, MD, FNLA; Timothy S. Rei

Read More

Article

Safety, tolerability, and nonglycemic effects of incretin-based therapies

Author:: Keith R. Campbell, PharmD, MBA, CDE; Michael E. Cobble, MD, FNLA; Timothy S. Reid, MD; Mansur E. Shomali, MD, CM

Read More

Article

Safety, tolerability, and nonglycemic effects of incretin-based therapies

Author:: Keith R. Campbell, PharmD, MBA, CDE; Michael E. Cobble, MD, FNLA; Timothy S. Rei

Read More

Article

Patient education and self-management

Author:: Keith R. Campbell, PharmD, MBA, CDE; Michael E. Cobble, MD, FNLA; Timothy S. Reid, MD; Mansur E. Shomali, MD, CM

Read More

Article

Introduction

Author:: Keith R. Campbell, PharmD, MBA, CDE; Michael E. Cobble, MD, FNLA; Timothy S. Reid, MD; Mansur E. Shomali, MD, CM

Read More